Viewing Study NCT00125606


Ignite Creation Date: 2025-12-26 @ 2:41 PM
Ignite Modification Date: 2026-05-05 @ 8:12 AM
Study NCT ID: NCT00125606
Status: TERMINATED
Last Update Posted: 2012-12-18
First Post: 2005-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide
Sponsor: University Hospital Muenster
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AML View
None allogeneic HSCT View
None reduced intensity conditioning View
None randomized trail View